Lozenord 5 mg/ml solution for injection for dogs and cats
Lozenord 5 mg/ml solution for injection for dogs and cats
Authorised
- Meloxicam
Product identification
Medicine name:
Lozenord 5 mg/ml solution for injection for dogs and cats
Lozenord 5 mg/ml solution for injection for dogs and cats
Active substance:
- Meloxicam
Target species:
-
Dog
-
Cat
Route of administration:
-
Intravenous use
-
Subcutaneous use
Product details
Active substance and strength:
-
Meloxicam5.00/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Solution for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QM01AC06
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Ireland
Package description:
- Type 1 glass vial of 10 ml with a grey chlorobutyl fluorotec rubber stopper and sealed with aluminium cap and flip off plastic tamper evident top. Cardboard box containing 1 vial of 10 ml.
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 18 of Regulation (EU) 2019/6)
Marketing authorisation holder:
- Accord Healthcare B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
- Fundacio Privada Dau
Responsible authority:
- Health Products Regulatory Authority
Authorisation number:
- VPA25237/002/001
Date of authorisation status change:
Reference member state:
-
Ireland
Procedure number:
- IE/V/0560/001
Concerned member states:
-
Belgium
-
France
-
Germany
-
Italy
-
Netherlands
-
Poland
-
Spain
-
United Kingdom (Northern Ireland)
Generic of:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
